CALGARY, Alberta, Oct. 08, 2026 (GLOBE NEWSWIRE) — Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug discovery company developing novel therapeutics for autism spectrum disorder (“ASD”) and related neurodevelopmental disorders, is pleased to announce preliminary results from its…
An employee at a plague research institute in Siberia, Darya Shipilova, employed at a plague research institute in Siberia fell ill and died in undisclosed circumstances.
Kenya’s laboratory network has tested 268 samples, with a turnaround time of approximately six to 12 hours to support timely public health interventions.
University Hospital Galway has apologised to a woman who was diagnosed with terminal brain cancer in 2023 after a number of scans were allegedly misinterpreted.
